We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Berkshire Sells 27.5M Bank of America Shares: Should Investors Worry?
Read MoreHide Full Article
Key Takeaways
Berkshire cut its Bank of America stake by 5.7% in Q3 2026, retaining 455.9M shares worth $24.8B.
BAC expects NII growth of 8% in 2026 and at least 8% in 2027, supporting earnings prospects.
BAC shares fell 1.2% in six months, while lower earnings estimates and institutional selling pose challenges.
Berkshire Hathaway has further reduced its stake in Bank of America (BAC - Free Report) , raising questions about investor confidence in the banking giant. Per its November 16 Form 13F filing, Berkshire sold approximately 27.5 million BAC shares during the third quarter of 2026, reducing its holding by 5.7% to 455.9 million shares. Although the sale was smaller than the earlier speculation of 30-40 million shares, continued reductions could weigh on market sentiment.
The latest transaction marks another quarter of Berkshire trimming its BAC exposure. The conglomerate has reduced its position by approximately 57.8 million shares since March 2026. Such persistent selling by a prominent institutional shareholder could create a sentiment overhang, particularly if investors interpret the move as declining conviction in BAC’s near-term upside potential.
However, Berkshire’s portfolio adjustments do not necessarily indicate deteriorating fundamentals at Bank of America. The conglomerate continues to hold a substantial stake, valued at approximately $24.8 billion as of September-end. The reductions could reflect portfolio diversification or capital reallocation rather than concerns about the bank’s financial health.
Importantly, BAC’s underlying earnings prospects remain encouraging. Third-quarter 2026 net interest income increased year over year, supported by asset repricing and lending activity. Management expects approximately 8% net interest income growth in 2026 and at least 8% growth in 2027. Continued deposit stability, loan growth and improving interest income could support profitability despite uncertainty surrounding Berkshire’s investment strategy.
Yet, further institutional selling could limit BAC’s near-term valuation upside and heighten share-price volatility. Elevated operating expenses, potential credit deterioration and interest-rate uncertainty also warrant attention. While Berkshire’s continued stake reductions may unsettle investors, BAC’s earnings resilience and favorable net interest income outlook suggest that the selling alone does not undermine its longer-term investment prospects.
How Do BAC’s Peers Compare?
The implications of Berkshire’s continued stake reductions extend beyond Bank of America, as investors assess the broader outlook for large U.S. banks. JPMorgan Chase (JPM - Free Report) , for instance, continues to benefit from its diversified business model, strong deposit franchise and multiple revenue streams. While BAC’s net interest income growth prospects remain favorable, JPMorgan’s diversified operations provide an additional cushion against interest-rate volatility and potential credit challenges.
Meanwhile, Capital One Financial (COF - Free Report) has also witnessed a reduction in Berkshire’s ownership. During the third quarter, Berkshire trimmed its Capital One stake by approximately 61.7%, a much sharper percentage decline than the 5.7% reduction in BAC. This suggests that Berkshire’s selling activity is not limited to Bank of America and could reflect broader portfolio rebalancing rather than concerns specific to BAC.
Nevertheless, the investment outlook for BAC, JPMorgan and Capital One will largely depend on their respective earnings performance, loan demand, credit quality and interest income trends.
BAC’s Price Performance, Valuation & Estimates
In the past six months, shares of Bank of America have lost 1.2% against the industry’s 5.6% growth.
Image Source: Zacks Investment Research
From a valuation standpoint, BAC trades at a trailing 12-month price-to-tangible book ratio of 1.78, below the industry average of 3.15.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for BAC’s 2026 and 2027 earnings indicates year-over-year growth rates of 18.4% and 14.9%, respectively. Earnings estimates for both years have been revised lower over the past 30 days.
Image: Bigstock
Berkshire Sells 27.5M Bank of America Shares: Should Investors Worry?
Key Takeaways
Berkshire Hathaway has further reduced its stake in Bank of America (BAC - Free Report) , raising questions about investor confidence in the banking giant. Per its November 16 Form 13F filing, Berkshire sold approximately 27.5 million BAC shares during the third quarter of 2026, reducing its holding by 5.7% to 455.9 million shares. Although the sale was smaller than the earlier speculation of 30-40 million shares, continued reductions could weigh on market sentiment.
The latest transaction marks another quarter of Berkshire trimming its BAC exposure. The conglomerate has reduced its position by approximately 57.8 million shares since March 2026. Such persistent selling by a prominent institutional shareholder could create a sentiment overhang, particularly if investors interpret the move as declining conviction in BAC’s near-term upside potential.
However, Berkshire’s portfolio adjustments do not necessarily indicate deteriorating fundamentals at Bank of America. The conglomerate continues to hold a substantial stake, valued at approximately $24.8 billion as of September-end. The reductions could reflect portfolio diversification or capital reallocation rather than concerns about the bank’s financial health.
Importantly, BAC’s underlying earnings prospects remain encouraging. Third-quarter 2026 net interest income increased year over year, supported by asset repricing and lending activity. Management expects approximately 8% net interest income growth in 2026 and at least 8% growth in 2027. Continued deposit stability, loan growth and improving interest income could support profitability despite uncertainty surrounding Berkshire’s investment strategy.
Yet, further institutional selling could limit BAC’s near-term valuation upside and heighten share-price volatility. Elevated operating expenses, potential credit deterioration and interest-rate uncertainty also warrant attention. While Berkshire’s continued stake reductions may unsettle investors, BAC’s earnings resilience and favorable net interest income outlook suggest that the selling alone does not undermine its longer-term investment prospects.
How Do BAC’s Peers Compare?
The implications of Berkshire’s continued stake reductions extend beyond Bank of America, as investors assess the broader outlook for large U.S. banks. JPMorgan Chase (JPM - Free Report) , for instance, continues to benefit from its diversified business model, strong deposit franchise and multiple revenue streams. While BAC’s net interest income growth prospects remain favorable, JPMorgan’s diversified operations provide an additional cushion against interest-rate volatility and potential credit challenges.
Meanwhile, Capital One Financial (COF - Free Report) has also witnessed a reduction in Berkshire’s ownership. During the third quarter, Berkshire trimmed its Capital One stake by approximately 61.7%, a much sharper percentage decline than the 5.7% reduction in BAC. This suggests that Berkshire’s selling activity is not limited to Bank of America and could reflect broader portfolio rebalancing rather than concerns specific to BAC.
Nevertheless, the investment outlook for BAC, JPMorgan and Capital One will largely depend on their respective earnings performance, loan demand, credit quality and interest income trends.
BAC’s Price Performance, Valuation & Estimates
In the past six months, shares of Bank of America have lost 1.2% against the industry’s 5.6% growth.
Image Source: Zacks Investment Research
From a valuation standpoint, BAC trades at a trailing 12-month price-to-tangible book ratio of 1.78, below the industry average of 3.15.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for BAC’s 2026 and 2027 earnings indicates year-over-year growth rates of 18.4% and 14.9%, respectively. Earnings estimates for both years have been revised lower over the past 30 days.
Image Source: Zacks Investment Research
Currently, Bank of America carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.